This content is in French.
Dupilumab in chronic spontaneous urticaria
7 mars 2024
Chronic spontaneous urticaria is a chronic inflammatory disease that can persist despite antihistamine or anti-IgE (omalizumab) treatments. In two randomized, placebo-controlled, double-blind Phase 3 clinical trials, researchers here…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Marcus Maurer et al. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): two randomized, double-blind, placebo-controlled, phase 3 trials. J Allergy Clin Immunol. 2024 Feb 29:S0091-6749(24)00196-9.
View the source
